Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) Short Interest Update

Bullfrog AI Holdings, Inc. (NASDAQ:BFRGGet Free Report) was the target of a significant increase in short interest in the month of July. As of July 15th, there was short interest totalling 442,600 shares, an increase of 352.6% from the June 30th total of 97,800 shares. Approximately 13.5% of the shares of the stock are short sold. Based on an average daily trading volume, of 173,100 shares, the days-to-cover ratio is currently 2.6 days.

Institutional Investors Weigh In On Bullfrog AI

An institutional investor recently bought a new position in Bullfrog AI stock. Fortem Financial Group LLC acquired a new stake in shares of Bullfrog AI Holdings, Inc. (NASDAQ:BFRGFree Report) in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 53,300 shares of the company’s stock, valued at approximately $171,000. Fortem Financial Group LLC owned approximately 0.68% of Bullfrog AI at the end of the most recent quarter. 0.96% of the stock is currently owned by hedge funds and other institutional investors.

Bullfrog AI Price Performance

NASDAQ BFRG traded down $0.22 on Friday, reaching $3.00. The company’s stock had a trading volume of 569,752 shares, compared to its average volume of 436,844. Bullfrog AI has a twelve month low of $1.43 and a twelve month high of $8.35. The firm’s 50 day moving average is $2.43 and its two-hundred day moving average is $3.33.

Bullfrog AI (NASDAQ:BFRGGet Free Report) last released its earnings results on Friday, May 10th. The company reported ($0.26) EPS for the quarter.

Bullfrog AI Company Profile

(Get Free Report)

Bullfrog AI Holdings, Inc, through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data.

See Also

Receive News & Ratings for Bullfrog AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bullfrog AI and related companies with MarketBeat.com's FREE daily email newsletter.